Asia Pacific Genomics Market is expected to reach US$ 11,574.11 million by 2027

DiagnosticsSegment Held Largest Share of Application in Asia Pacific Genomics Market in 2019

According to The Insight Partners market research study of ‘Asia Pacific Genomics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by technology, product and service, application, and end-user’ the Asia Pacific Genomics market is expected to reach US$ 11,574.11 million in 2027 from US$ 4,269.80 million in 2019. The market is estimated to grow with a CAGR of 13.6% from 2020-2027. The report provides trends prevailing in the Asia Pacific Genomics market and the factors driving market along with those that act as hindrances.

Based on the application, the Asia Pacific the Genomics market, is segmented into diagnostics, drug discovery and development, precision/personalized medicine, agriculture & animal research, and others. The diagnostics segment held the largest share of the market in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period. The diagnostic segment's growth is fuelled due to factors such as the launch of innovative diagnostic products, increasing investment in genome technologies and expanding capabilities of the genomics in diagnostic applications. Furthermore, advancements in the field of genomics are driving the growth of the diagnostic application segment. For instance, in November 2019, Neuberg Diagnostics Pvt Ltd launched a Neuberg Center for Genomic Medicine in Ahmedabad. It also inaugurated the NOVASEQ 6000 - the highest throughput DNA sequencer currently available globally.

The growth of this market is estimated to grow owing to key driving factors such as the rising adoption of precision medicines across Asia Pacific and the growth in government programs concerning genomics. However, the market growth is likely to be hindered owing to the multiple issues encountered by professionals regarding genomics market.

Illumina, Inc., Danaher, F. HOFFMANN-LA ROCHE LTD. are among the leading companies operating in the Asia Pacific Genomics market. 

The report segments Asia Pacific Genomics Market as Follows:

By Technology

• Sequencing
• Microarray
• Polymerase Chain Reaction
• Nucleic Acid Extraction and Purification
• Others

By Product and Services

• Instruments/Systems
• Consumables
• Services

By Application

• Diagnostics
• Drug Discovery and Development
• Precision/Personalized Medicine
• Agriculture & Animal Research
• Others

By End User

• Research Centers
• Hospitals & Clinics
• Biotechnology & Pharmaceutical Companies
• Others

By Country

• Asia Pacific

• • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific